2017

April 20 2017
First European Patients Treated With DC Bead LUMI™ Radiopaque Drug-Eluting Beads

London, UK, 20 April 2017 BTG plc (LSE: BTG), a global specialist healthcare company, today announced the treatment of the first patients in the EU with DC Bead LUMI™. Two patients were treated...

April 06 2017
BTG plc: close period update

London, UK, 06 April 2017 BTG plc (LSE:BTG), the specialist healthcare company, provides the following update for the year ended 31 March 2017 ahead of the publication of its Final Results on 16...

March 07, 2017
SnakeBite911™ Expands Free Snake Education and Snakebite Safety App to Android Devices

West Conshohocken, PA, 07 March 2017 BTG plc (LSE:BTG), an international specialist healthcare company, today announced that SnakeBite911™, the company’s consumer-friendly app containing...

March 07, 2017
BTG announces CE Mark Certification for DC Bead LUMI™, the first commercially available radiopaque drug-eluting bead in the EU

London, UK, 07 March 2017 DC Bead LUMI™ provides real-time visible, lasting confirmation of bead location during and post-embolisation of hypervascular tumours in the liver BTG plc (LSE: BTG), a...

February 27, 2017
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

London, UK, 27 February 2017 BTG plc (LSE: BTG), the global specialist healthcare company, today announced U.S. Food and Drug Administration 510(k) clearance has been granted to the EKOS® Control...

Show 5102550100 per page
Top